Finazzi G - Search Results

1

Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation.

De Stefano V, Za T, Rossi E, Vannucchi AM, Ruggeri M, Elli E, Micò C, Tieghi A, Cacciola RR, Santoro C, Vianelli N, Guglielmelli P, Pieri L, Scognamiglio F, Cacciola E, Rodeghiero F, Pogliani EM, Finazzi G, Gugliotta L, Leone G, Barbui T; GIMEMA Chronic Myeloproliferative Neoplasms Working Party. De Stefano V, et al. Among authors: finazzi g. Ann Hematol. 2010 Feb;89(2):141-6. doi: 10.1007/s00277-009-0788-5. Epub 2009 Jul 7. Ann Hematol. 2010. PMID: 19582452

2

Inefficacy of intravenous immunoglobulin in patients with low-risk thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome.

Finazzi G, Bellavita P, Falanga A, Viero P, Barbui T. Finazzi G, et al. Am J Hematol. 1992 Nov;41(3):165-9. doi: 10.1002/ajh.2830410305. Am J Hematol. 1992. PMID: 1415190

3

A frameshift mutation leading to type 1 antithrombin deficiency and thrombosis.

Olds RJ, Lane DA, Finazzi G, Barbui T, Thein SL. Olds RJ, et al. Among authors: finazzi g. Blood. 1990 Dec 1;76(11):2182-6. Blood. 1990. PMID: 1979501 Free article.

4

High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura.

Cortelazzo S, Finazzi G, Buelli M, Molteni A, Viero P, Barbui T. Cortelazzo S, et al. Among authors: finazzi g. Blood. 1991 Jan 1;77(1):31-3. Blood. 1991. PMID: 1984800 Free article.

5

A retrospective study on oral anticoagulant prophylaxis in 103 Italian patients with hereditary thrombophilia and thrombosis. ad hoc Study Group.

Finazzi G, Barbui T. Finazzi G, et al. Ric Clin Lab. 1990 Oct-Dec;20(4):245-52. doi: 10.1007/BF02900709. Ric Clin Lab. 1990. PMID: 2075376

6

[Congenital deficiency of antithrombin III].

Finazzi G, Barbui T. Finazzi G, et al. Haematologica. 1990 Mar-Apr;75 Suppl 2:6-13. Haematologica. 1990. PMID: 2201606 Review. Italian. No abstract available.

7

Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia.

Cortelazzo S, Viero P, Finazzi G, D'Emilio A, Rodeghiero F, Barbui T. Cortelazzo S, et al. Among authors: finazzi g. J Clin Oncol. 1990 Mar;8(3):556-62. doi: 10.1200/JCO.1990.8.3.556. J Clin Oncol. 1990. PMID: 2307991

8

Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.

Galli M, Finazzi G, Bevers EM, Barbui T. Galli M, et al. Among authors: finazzi g. Blood. 1995 Jul 15;86(2):617-23. Blood. 1995. PMID: 7605991 Free article.

9

Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis.

Cortelazzo S, Finazzi G, Ruggeri M, Vestri O, Galli M, Rodeghiero F, Barbui T. Cortelazzo S, et al. Among authors: finazzi g. N Engl J Med. 1995 Apr 27;332(17):1132-6. doi: 10.1056/NEJM199504273321704. N Engl J Med. 1995. PMID: 7700286 Free article. Clinical Trial.

10

Clinical trials on antiphospholipid syndrome: what is being done and what is needed?

Barbui T, Finazzi G. Barbui T, et al. Among authors: finazzi g. Lupus. 1994 Aug;3(4):303-7. doi: 10.1177/096120339400300419. Lupus. 1994. PMID: 7804321 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

373 results

Search Page

Filters